Efficacy of Tezepelumab in Peanut Oral Immunotherapy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy of Tezepelumab in Peanut Oral Immunotherapy	Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder	Recruiting	Phase 2	2026-09-16		NCT07015996

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Immune Tolerance Network (ITN)	7
National Institute of Allergy and Infectious Diseases (NIAID)	402
PPD Development, LP	27
Rho Federal Systems Division, Inc.	12

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology	Little Rock	United States	3
Boston Children's Hospital: Allergy and Asthma Program	Boston	United States	2
Cincinnati Children's Hospital Medical Center: Division of Allergy and Immunology	Cincinnati	United States	2
Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology	New York	United States	1
Johns Hopkins Children's Center: Department of Allergy & Immunology	Baltimore	United States	2
Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit	Boston	United States	1
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology	Chapel Hill	United States	4
The University of Michigan: Division of Allergy and Clinical Immunology	Ann Arbor	United States	1
University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy	Los Angeles	United States	1
University of Texas Southwestern Medical Center: Division of Allergy and Immunology	Dallas	United States	1